{"name":"Shattuck Labs","slug":"shattuck","ticker":"STTK","exchange":"NASDAQ","domain":"shattucklabs.com","description":"Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.","hq":"Austin, TX","founded":0,"employees":"40","ceo":"Taylor Schreiber, M.D., Ph.D.","sector":"Immuno-Oncology","stockPrice":6.73,"stockChange":-0.05,"stockChangePercent":-0.74,"marketCap":"$482M","metrics":{"revenue":2000000,"revenueGrowth":0,"grossMargin":-195.1,"rdSpend":0,"netIncome":-48809000,"cash":78065000,"dividendYield":0,"peRatio":-14.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"SL-172 patent cliff ($0.00B at risk)","drug":"SL-172","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"Shattuck Labs Announces FDA Clearance of IND for SL-172","summary":"Shattuck Labs announced that the FDA has cleared the Investigational New Drug (IND) application for SL-172, a CD73 inhibitor being developed for the treatment of various cancers.","drugName":"SL-172","sentiment":"positive"},{"date":"2023-11-14","type":"earnings","headline":"Shattuck Labs Reports Third Quarter 2023 Financial Results","summary":"Shattuck Labs reported its third quarter 2023 financial results, with a net loss of $13.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-08-16","type":"deal","headline":"Shattuck Labs Announces Collaboration with Merck KGaA","summary":"Shattuck Labs announced a collaboration with Merck KGaA to develop and commercialize SL-172 for the treatment of various cancers.","drugName":"SL-172","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOMy1PUEs5UEpMdElUS2hIV3F3d1EzYkVVMkE3aE1OY240UEl4dTdNY1RGaU1rcGMtSG4xNUR2V0Q5Um14LWZ2MURVWDZPbDNBbWxOczlIZDhWVS1QaWhUdEU0Z2tzRUdrcHBmNFlmSldTSDFfb3BwNzQtclhfckZXSEdSLUNLanp2dDlSUUtZX0pjRk1yZzA3dEpBWG51RmpIeWhBQmhlR2lLRlUxTFJwc09tVDg1VWxyTEE?oc=5","date":"2026-03-06","type":"trial","source":"AD HOC NEWS","summary":"Shattuck Labs (STTK, US8124231002): What Recent Data Mean For Global Biotech Investors - AD HOC NEWS","headline":"Shattuck Labs (STTK, US8124231002): What Recent Data Mean For Global Biotech Investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMjA5UkVtNVA2dFF3TnpOcXRNYnlQM09LaXplRFJ1YnREMDF1UVVKMW9BNW5Wc016WUR4TTFmNEM5dUdOWUhVMTBKZC1rNmRCdWhSUW0zS0ozcUpNaG1iSmxRemJtLXczTXFEMlNDdFVvRFl4ZGEwbFlDc3otT0V3Qko0T0VwSUtqNlpVM18zLUNHOTA1SG5yYTdrejhLSU1pZnFRdHdEVjFaZ0lUdE1aZ0s5T2RDeThKc2NVRTNBaUpwZWc?oc=5","date":"2026-02-16","type":"pipeline","source":"AD HOC NEWS","summary":"Shattuck Labs Just Shocked Wall Street: Is STTK the Next Sleeper Biotech Rocket or Total Trap? - AD HOC NEWS","headline":"Shattuck Labs Just Shocked Wall Street: Is STTK the Next Sleeper Biotech Rocket or Total Trap?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"deal","source":"simplywall.st","summary":"Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline - simplywall.st","headline":"Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQY09WV1Y0THdRUDIzSldIdHRTeWdRVjVrOTZ4UTlvMjBNOFVOYnJseE5CZGxZZDJNU2U5M0Etdm9qUzdSYnhpUlVUYnhxVks0cDIxME9YbTVPUEVCZnlQUmVIbm5YaGdHRkpLbFN1YU00czhpUmtNeWhjXzlVblJacm91cHpfMEdtdXdITEg3ZTdnR2ZXV1pHcWVXdkVoXzh6MjRaN1VOSFE0N1FRUGU3eHF3ZjEzTERkLVo3ZGVn?oc=5","date":"2026-01-16","type":"pipeline","source":"Seeking Alpha","summary":"Shattuck Labs: \"Hold\" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK) - Seeking Alpha","headline":"Shattuck Labs: \"Hold\" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-30","type":"pipeline","source":"simplywall.st","summary":"Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week - simplywall.st","headline":"Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMFA5a3Bkbm00MnM4MkJkWFFNMXFnNFZHenhQSGZMWkpKdEh5VlRaOTQ3dTlUb0xEZ0laT2ZhT2FNZDZHWnUxZUdqRzl5clg4ejNBUG54UnJ4YmZxLUVMYU8wVXpmTkhrRG5jaHZWckhkcDZRNm4tS21UVHkza0xsM1E3eF80Z2VMWHFlR2JJNEFlZ0lZQkJqdU1SRW92TWFOUWlJa1BuMkRENjNWTFMzVHV3di0xNU5sTHpOTw?oc=5","date":"2025-08-05","type":"pipeline","source":"Stock Titan","summary":"Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million - Stock Titan","headline":"Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB5eU5BU1BON25tZVhtZV8tOEhnRXRJQ2hWeTZsZ3F2REZyOXl3OVo0THY3bHdMZjN3OEN6Nnc5NE5VN1M1Q1VSRmJxMktRdWdSWlNJ?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"STTK Stock Price, News & Analysis - Stock Titan","headline":"STTK Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1CLVp5SHpHWXQ0VWtKVWxSc0dCLTd3cm9GMVRRVHEza25GWW41TjVCcW9QZi1EODlOOHNJc0M0amNjOHExanpDQV9UWm9rOGlXVHd5dEFrdWJTOGVQc3hhekxnRm9wQQ?oc=5","date":"2024-05-11","type":"pipeline","source":"MarketBeat","summary":"Shattuck Labs (STTK) Stock Forecast and Price Target 2026 $STTK - MarketBeat","headline":"Shattuck Labs (STTK) Stock Forecast and Price Target 2026 $STTK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBhNm1obkpSR0l6R1RHX3dfU3psZXN4WHJ2QUx4LW9oWWowMlFEcHVhZFFqM2VqbWVsdkVXbEpCZkUxWUNWQWc0R1hhREZwTnVoenVRODBaRVpBT1FZSGhz?oc=5","date":"2021-02-23","type":"pipeline","source":"ChartMill","summary":"STTK Stock Price, Quote & Chart | SHATTUCK LABS INC (NASDAQ:STTK) - ChartMill","headline":"STTK Stock Price, Quote & Chart | SHATTUCK LABS INC (NASDAQ:STTK)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBvbHZVWmVZb1BKYmhZaTVULWhCZHIwdlR4R29KNlZteW9BaDEwdGprZHVxeTZ6eW5rSTUwZ01DQzhJZGtydGdtVUZFX2lfY3c4RHdZS29xRnhUdw?oc=5","date":"2020-10-10","type":"pipeline","source":"MarketBeat","summary":"Shattuck Labs (STTK) Stock Price, News & Analysis $STTK - MarketBeat","headline":"Shattuck Labs (STTK) Stock Price, News & Analysis $STTK","sentiment":"neutral"}],"patents":[{"drugName":"SL-172","drugSlug":"cd73-inhibitor","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Bristol Myers Squibb","Merck & Co.","AstraZeneca"],"therapeuticFocus":["Immuno-Oncology"],"financials":null,"yahoo":{"currentPrice":6.73,"previousClose":6.78,"fiftyTwoWeekHigh":6.95,"fiftyTwoWeekLow":0.71,"fiftyTwoWeekRange":"0.712 - 6.9485","fiftyDayAverage":4.94,"twoHundredDayAverage":2.74,"beta":1.29,"enterpriseValue":409561376,"forwardPE":-14.1,"priceToBook":5.17,"priceToSales":481.63,"enterpriseToRevenue":409.56,"enterpriseToEbitda":-8.58,"pegRatio":0,"ebitda":-47739000,"ebitdaMargin":0,"freeCashflow":-21513876,"operatingCashflow":-39882000,"totalDebt":2421000,"debtToEquity":2.9,"currentRatio":11.7,"returnOnAssets":-35.3,"returnOnEquity":-60.3,"analystRating":"","recommendationKey":"none","numberOfAnalysts":6,"targetMeanPrice":10,"targetHighPrice":15,"targetLowPrice":6,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":9.8,"institutionHeldPercent":67.3,"sharesOutstanding":71564217,"floatShares":46220465,"sharesShort":1579942,"shortRatio":2.52,"shortPercentOfFloat":2.2,"epsTrailing":-0.7,"epsForward":-0.48,"revenuePerShare":0.01,"bookValue":1.3,"officers":[{"age":45,"name":"Dr. Taylor H. Schreiber M.D., Ph.D.","title":"Co-Founder, CEO & Director"},{"age":39,"name":"Mr. Andrew R. Neill M.B.A.","title":"Chief Financial Officer"},{"age":65,"name":"Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.","title":"Chief Medical Officer"},{"age":null,"name":"Mr. Brad  Huckabee","title":"Vice President of Accounting & SEC reporting"},{"age":51,"name":"Dr. Abhinav A. Shukla Ph.D.","title":"Chief Technical Officer"},{"age":49,"name":"Dr. Stephen  Stout J.D., Ph.D.","title":"General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer"},{"age":54,"name":"Ms. Casi  DeYoung","title":"Chief Business Officer"},{"age":null,"name":"Dr. Thomas  Lampkin Pharm.D.","title":"Senior Vice President of Regulatory Affairs"}],"industry":"Biotechnology","irWebsite":"","website":"https://www.shattucklabs.com","phone":"512 900 4690"}}